-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on TuHURA Biosciences, Maintains $10 Price Target

Benzinga·10/27/2026 16:43:35
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates TuHURA Biosciences (NASDAQ:HURA) with a Buy and maintains $10 price target.